CDKN2A and cancer: Although cancer cells often exhibit upregulated nucleotide biosynthesis pathways, and historically antimetabolites including antifolates have been used as chemotherapy, their potential efficacy in targeting p16/CDKN2Alow tumors remains widely underexplored.